Key facts
- This page summarizes Dimitar Slavchev Savov's Form 4 filing for NIKA PHARMACEUTICALS, INC (NIKA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Mar 2025, 15:31.
Dimitar Slavchev Savov - 18 Mar 2025 Form 4 Insider Report for NIKA PHARMACEUTICALS, INC (NIKA)
- Reporting relationship
- CEO, CFO, President, Director, 10%+ Owner
- Issuer ticker
- NIKA
- Reported as of
- 18 Mar 2025
- Net transaction value
- -$500,000
- Reporting owner signature
- /s/Dimitar Slavchev Savov
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Dimitar Slavchev Savov filed Form 4 for NIKA PHARMACEUTICALS, INC (NIKA) on 19 Mar 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$500,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NIKA
transaction
Common Stock
Sale
- Transaction value
- $500,000
- Shares
- -2,000,000
- Change %
- -0.44%
- Price
- $0.2500
- Shares after
- 455,589,500
- Date
- 18 Mar 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.